Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-23-013552

Director acquired 3,027 shares (code L)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Krogulski Kenneth Director 2023-10-02 Other acquisition +280 $1.89 $529 219,446 D
Krogulski Kenneth Director 2023-10-03 Other acquisition +280 $1.85 $518 219,726 D
Krogulski Kenneth Director 2023-10-04 Other acquisition +227 $1.79 $406 219,953 D
Krogulski Kenneth Director 2023-10-05 Other acquisition +280 $1.85 $518 220,233 D
Krogulski Kenneth Director 2023-10-06 Other acquisition +280 $1.88 $526 220,513 D
Krogulski Kenneth Director 2023-10-09 Other acquisition +280 $2.06 $577 220,793 D
Krogulski Kenneth Director 2023-10-10 Other acquisition +280 $2.04 $571 221,073 D
Krogulski Kenneth Director 2023-10-11 Other acquisition +280 $2.04 $571 221,353 D
Krogulski Kenneth Director 2023-10-12 Other acquisition +280 $2.13 $596 221,633 D
Krogulski Kenneth Director 2023-10-13 Other acquisition +280 $2.07 $580 221,913 D
Krogulski Kenneth Director 2023-10-16 Other acquisition +280 $2.03 $568 222,193 D
Loading xslF345X05/marketforms-63405.xml…